Treatment of benign prostatic hypertrophy with medrogestone.
D000368:Aged; D001706:Biopsy; D001786:Blood Glucose / Q000032:analysis; D002986:Clinical Trials as Topic; D003558:Cystoscopy; D006062:Gonadotropins / Q000652:urine; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007659:Ketones / Q000627:therapeutic use; D008297:Male; D010919:Placebos; D011278:Pregnanes / Q000009:adverse effects / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D013739:Testosterone / Q000652:urine; D014555:Urination Disorders / Q000188:drug therapy; D014567:Urography
D001786:Blood Glucose; D006062:Gonadotropins; D007659:Ketones; D010919:Placebos; D011278:Pregnanes; D013739:Testosterone; D006854:Hydrocortisone